Company intelligence
Cartesian Therapeutics
Pioneering RNA cell therapy for autoimmune disease
Biotechnology Research
Frederick, US
102 employees
Founded 2016
1 public signals
About Cartesian Therapeutics
Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis with plans to initiate a Phase 2 trial in myositis. For more information, please visit www.cartesiantherapeutics.com.
Verified activity
Signals from Cartesian Therapeutics
1 published signal